METHYL (R)-N-BOC-3-PHENYL-BETA-ALANINATE, 97.0%, 250mg

4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide, 95.0%, 5g

Tetrahydrothiopyran-4-one oxime, 97%, 100g

3-(((tert-Butoxycarbonyl)amino)methyl)-4-fluorobenzoic acid, 97%, 5g

5-Bromo-N,4-dimethyl-3-nitropyridin-2-amine, 95.0%, 1g

3,6-Dihydroxy-xanthen-9-one, 95.0%, 1g

1-Hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid, 95%, 250mg

1-Bromo-2,4,5-trichlorobenzene, 95.0%, 10g

4-(3-NITROPHENOXY)BENZAMIDE, 95.0%, 250mg

5-Fluoroorotic acid, min. 98%, for biochemistry, 2.5 g, glass packaging

Platform scale Ranger® 3000 series Models not certified, 1 g, 30000 g, R31P30

anti-Cardiac Actin mouse monoclonal, AC1-20.4.2, 1 ml

1-(4-AMINO-1-METHYL-1H-PYRAZOL-3-YL)ETHANONE, 95.0%, 100mg